A carregar...
Immune response in LPD during methotrexate administration (MTX-LPD) in rheumatoid arthritis patients
Methotrexate (MTX) is known as a first-line synthetic disease-modifying anti-rheumatic drug (DMARD) for the treatment of rheumatoid arthritis (RA). Although the risk of LPD development increases by RA inflammation itself, observation of spontaneous regression of LPD after MTX discontinuation lead to...
Na minha lista:
| Publicado no: | J Clin Exp Hematop |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
JSLRT
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6954173/ https://ncbi.nlm.nih.gov/pubmed/31866617 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3960/jslrt.19028 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|